Literature DB >> 17575505

Indications for genetic referral: a guide for healthcare providers.

Beth A Pletcher1, Helga V Toriello, Sarah J Noblin, Laurie H Seaver, Deborah A Driscoll, Robin L Bennett, Susan J Gross.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17575505      PMCID: PMC3110962          DOI: 10.1097/gim.0b013e318064e70c

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


× No keyword cloud information.
As genetic health professionals, we are frequently asked under what clinical circumstances a genetic consultation is warranted. Although there is a vast array of indications for referral, here are a number of common indications for a genetic office visit. These lists have been divided into pediatric, preconceptional/prenatal, and adult categories for simplicity’s sake; findings are paired with consultation objectives. These lists are clearly not intended to be exhaustive or comprehensive, but will hopefully serve as a guide for primary care providers who may have questions about specific clinical circumstances. As the field of genetics expands and genetic technologies uncover new genes and genetic associations on a weekly basis, these lists will quickly become outdated. However, for now, these may help to provide a framework for patient centered specialty referrals (Tables 1–3).
Table 1

Genetic consultation may be helpful under the following circumstances for preconceptional or prenatal patients

Prenatal or preconceptional patient who is or will be:

FindingReason to consider consultation

Age 35 years or older at the time of delivery (for a singleton pregnancy)Discuss testing options for identifying an age-related chromosome anomaly
Age 33 years or older at the time of delivery (for a twin pregnancy)Discuss testing options for identifying an age-related chromosome anomaly
A close blood relative of her partner (consanguineous union)Review pedigree and assess degree of relatedness; discuss potential additional fetal risks and testing options before and/or after delivery
Prenatal or preconceptional patient who has:

FindingReason to consider consultation

An abnormal first or second trimester maternal serum ± nuchal translucency screening testDiscuss risks to pregnancy and testing options
Exposure to a teratogen or potentially teratogenic agent during gestation such as radiation, high-risk infections (cytomegalovirus, toxoplasmosis, rubella), drugs, medications, alcohol, etc.Discuss risks to pregnancy and testing options and rule out significant fetal ± maternal risks
A fetal anomaly or multiple anomalies identified on ultrasound and/or through echocardiographyDiscuss risks to pregnancy and testing options
A personal or family history of pregnancy complications known to be associated with genetic factors such as acute fatty liver of pregnancyRule out significant fetal risks ± maternal risks, including a metabolic disorder
Either member of the couple with:

FindingReason to consider consultation

A positive carrier screening test for a genetic condition such as cystic fibrosis, thalassemia, sickle cell anemia, Tay-Sachs, etc.Discuss additional testing strategies and inheritance
A personal history of stillbirths, previous child with hydrops, recurrent pregnancy losses (more than two), or a child with sudden infant death syndrome (SIDS)Rule out a chromosomal, metabolic, or syndromic diagnosis that may be associated with an unexplained neonatal death or SIDS
A progressive neurologic condition known to be genetically determined such as a peripheral neuropathy, unexplained myopathy, progressive ataxia, early onset dementia, or a familial movement disorderDiscuss a potential diagnosis, the differential diagnosis, inheritance, and testing options
A statin-induced myopathyDiscuss a potential mitochondrial disorder, inheritance and testing options
Either member of the couple with a family or personal history of:

FindingReason to consider consultation

A birth defect such as a cleft lip ± palate, spina bifida, or a congenital heart defectDiscuss recurrence risks and testing options; discuss folate supplementation, if appropriate, for subsequent pregnancies
A chromosomal abnormality such as a translocation, marker chromosome, or chromosomal mosaicismDiscuss risks to the fetus and testing options
Significant hearing or vision loss thought to be genetically determinedDiscuss risks to the fetus and testing options
Mental retardation or autismDiscuss risks to the fetus and testing options
Table 3

Genetic consultation may be helpful under the following circumstances for pediatric patients

A neonate with:

FindingReason to consider consultation

An abnormal newborn screening testRule out an inborn error of metabolism or other treatable condition; provide genetic counseling about recurrence risks
Congenital hypotonia or hypertoniaRule out a chromosomal, metabolic, or syndromic diagnosis (e.g., Prader-Willi syndrome, congenital myotonic dystrophy, hyperekplexia).
Unexplained intrauterine growth retardationRule out a chromosomal or syndromic diagnosis (e.g., Russell-Silver syndrome, trisomy 18)
A neonate, infant, or child with:

FindingReason to consider consultation

A single major, or multiple major and/or minor anomaliesRule out a chromosomal or syndromic diagnosis; provide genetic counseling for recurrence and possible preventive measures (e.g., folate supplementation in subsequent pregnancies)
Dysmorphic features that are not familial, especially if accompanied by developmental delay or mental retardationRule out a chromosomal or syndromic diagnosis (numerous conditions)
Failure to thriveRule out a chromosomal, metabolic, or syndromic diagnosis, or genetic condition (e.g., IGF1R mutations)
A known metabolic disorder or symptoms of a metabolic disorder such as intractable seizures, hepatosplenomegaly, acidosis, cyclic vomiting, persistent hypoglycemia, developmental regression, and unusual body odorDiagnose an inborn error of metabolism; discuss treatment and management; provide genetic counseling
Abnormal brain MRI findings such as leukodystrophy, periventricular calcifications, unidentified bright objects, or a malformationRule out a chromosomal or syndromic diagnosis (e.g., neurofibromatosis, tuberous sclerosis); provide genetic counseling (e.g., some brain malformations such as Dandy-Walker malformation may be genetic)
An unusual growth pattern such as overgrowth, short stature, or hemihypertrophyRule out a chromosomal, syndromic, or metabolic diagnosis (e.g., Sotos syndrome, Beckwith-Wiedemann syndrome, Turner syndrome)
Evidence of a connective tissue disorder such as extreme joint laxity, poor wound healing, or a marfanoid habitusRule out a connective tissue disorder, such as Ehlers-Danlos syndrome, Marfan syndrome
Congenital eye defects or blindness associated with problems such as microophthalmia, cataracts, megalocornea, retinitis pigmentosa, or cone-rod dystrophyRule out a syndromic diagnosis; provide genetic counseling for potentially hereditary ocular conditions
Significant hearing loss or deafness not secondary to recurrent otitis mediaRule out a syndromic form of hearing loss (e.g., Waardenburg syndrome) or identify a genetic form of nonsyndromic hearing loss
Cardiomyopathy not secondary to a viral infectionRule out a mitochondrial disorder or other syndromic or metabolic diagnosis (e.g., carnitine deficiencies, Noonan syndrome, several forms of muscular dystrophy); provide genetic counseling for potentially hereditary forms of cardiomyopathy
Six or more café-au-lait macules >0.5 cm in diameterRule out neurofibromatosis type 1
Unusual skin findings such as multiple types of lesions, multiple lipomas, numerous hypo- or hyperpigmented lesions, and albinismRule out a chromosomal or syndromic diagnosis (e.g., chromosomal mosaicism, tuberous sclerosis, Cowden syndrome)
Born to a parent with a known chromosomal abnormality or rearrangement (balanced or unbalanced), especially if there are dysmorphic features and/or cognitive impairmentRule out a chromosomal abnormality
Bilateral or multifocal malignancies such as retinoblastoma or Wilms tumorRule out a cancer syndrome or other chromosomal or syndromic diagnosis (e.g., aniridia-Wilms tumor caused by 11p13 deletion); provide genetic counseling for recurrence
Problems with clotting including disorders such as hemophilia and thrombophiliaRule out an inherited clotting disorder as well as some syndromes (e.g., Noonan syndrome)
A recognized or suspected genetic syndrome including a chromosomal or single gene disorderConfirm the diagnosis and discuss the prognosis, medical management, inheritance, and recurrence risks
A significant family history of medical or psychiatric conditions that puts the patient at risk of developing the same or similar disorderDiscuss diagnosis, inheritance, and possible testing options
A child with:

FindingReason to consider consultation

Unexplained mental retardation or global developmental disorderRule out a chromosomal, syndromic or metabolic diagnosis (e.g., fragile X, sex chromosome anomaly, some forms of mucopolysaccharidoses)
Autism or pervasive developmental disorderRule out a chromosomal or syndromic diagnosis (e.g., fragile X, Angelman syndrome, Rett syndrome)
Unusual behaviors, especially when associated with minor malformations and developmental delay or mental retardationRule out a chromosomal or syndromic diagnosis (e.g., Smith-Magenis syndrome, Lesch-Nyhan syndrome)
An immunodeficiency or significant immune problemRule out a syndromic diagnosis (e.g., 22q deletion) or genetic form of immunodeficiency (e.g., severe combined immunodeficiency syndrome)
Progressive muscle weakness that might be associated with a genetic disorder such as a form of muscular dystrophy, spinal muscular atrophy, or myotonic dystrophyConfirm suspected diagnosis and provide genetic counseling
Other neurologic condition that might be associated with a genetic predisposition such as a peripheral neuropathy, unexplained myopathy, progressive ataxia, or any progressive neurologic disorder without a clear, nongenetic causeRule out a genetic diagnosis (e.g., spinocerebellar ataxia, Huntington disease), provide genetic counseling
Table 2

Genetic consultation may be helpful under the following circumstances for adult patients

Personal history of:

FindingReason to consider consultation

Abnormal sexual maturation or delayed pubertyRule out an intersex condition, chromosomal abnormality or syndromic diagnosis (e.g., androgen insensitivity, Klinefelter syndrome)
Recurrent pregnancy losses (RPLs) (more than 2)Rule out a chromosomal rearrangement such as a balanced translocation or inversion; causes 5%–7% of RPLs
Tall or short stature for genetic backgroundRule out a skeletal dysplasia, chromosomal or syndromic diagnosis (e.g., dyschondrosteosis, Klinefelter syndrome, Marfan syndrome)
One or more birth defectsRule out a chromosomal or syndromic diagnosis (e.g., 22q deletion, Noonan syndrome); provide genetic counseling and discussion of preconception folate supplementation, if appropriate
Six or more café-au-lait macules > 1.5 cm in diameterRule out neurofibromatosis type 1
Statin-induced myopathyRule out a mitochondrial disorder
Personal or family history of:

FindingReason to consider consultation

A cancer or cancers known to be associated with specific genes or mutations such as breast, ovarian, and colorectal in the context of a compelling family history; young age at onset, bilateral lesions, and familial clustering of related tumorsRule out an identifiable mutation in a gene such as BRCA1, FAP, etc.; rule out a cancer syndrome (e.g., MEN2 or von Hippel-Lindau); discuss surveillance, treatment, testing options (if presymptomatic), and inheritance
Cardiovascular problems known to be associated with genetic factors such as cardiomyopathy, long QT, hyperlipidemia, etc.Rule out a mutation in a causative or contributory gene; discuss surveillance, treatment, testing options, and inheritance
Suspected genetic disorder affecting connective tissueRule out a syndromic diagnosis (e.g., Ehlers-Danlos, Marfan syndrome, familial joint hypermobility); discuss surveillance, treatment, testing options, and inheritance
Hematologic condition associated with excessive bleeding or excessive clotting (as evidenced by recurrent deep vein thromboses or pulmonary emboli)Confirm or rule out genetic condition (e.g., one of the hemophilias, von Willebrand, one of the genetic thrombophilias); discuss treatment, testing options, and inheritance
Progressive neurologic condition known to be genetically determined such as a peripheral neuropathy, unexplained myopathy, progressive ataxia, early-onset dementia, and a familial movement disorderConfirm or rule out suspected diagnosis, discuss surveillance, treatment, testing options, and inheritance
Visual loss known to be associated with genetic factors such as retinitis pigmentosa, early-onset macular degeneration, and cataractsRule out a syndromic diagnosis (e.g., Stickler syndrome); discuss testing options, if applicable, and inheritance
Early-onset hearing lossRule out a syndromic or nonsyndromic genetic form of hearing loss; discuss surveillance, testing options, and inheritance
Recognized genetic disorder including a chromosomal or single gene disorderConfirm the diagnosis; discuss prognosis, medical management, and inheritance
Mental illness such as schizophrenia, depression, bipolar disorder, etc.Discuss diagnosis, inheritance, recurrence risks, and identify syndromes (e.g., 22q deletion), when possible
Family history of:

FindingReason to consider consultation

A close relative with a sudden, unexplained death, particularly at a young ageRule out a genetic condition associated with this history, e.g., long QT, Marfan syndrome, and other cardiac conditions
  11 in total

1.  Clinical Pharmacogenomics: Applications in Nephrology.

Authors:  Solomon M Adams; Karryn R Crisamore; Philip E Empey
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-23       Impact factor: 8.237

2.  The evolution of cancer risk assessment in the era of next generation sequencing.

Authors:  Heather Fecteau; Kristen J Vogel; Kristen Hanson; Shannon Morrill-Cornelius
Journal:  J Genet Couns       Date:  2014-04-24       Impact factor: 2.537

3.  Genetic Counseling in Portugal: Education, Practice and a Developing Profession.

Authors:  Milena Paneque; Álvaro Mendes; Jorge Saraiva; Jorge Sequeiros
Journal:  J Genet Couns       Date:  2015-03-03       Impact factor: 2.537

4.  The family medical history as a tool in preconception consultation.

Authors:  Robin L Bennett
Journal:  J Community Genet       Date:  2012-07-19

Review 5.  Genetic counseling for isolated GnRH deficiency.

Authors:  Margaret G Au; William F Crowley; Cassandra L Buck
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

6.  Underutilization of genetics services for autism: the importance of parental awareness and provider recommendation.

Authors:  Kimberly Vande Wydeven; Andrea Kwan; Antonio Y Hardan; Jonathan A Bernstein
Journal:  J Genet Couns       Date:  2012-03-14       Impact factor: 2.537

7.  Efficacy of a medical genetics rotation during pediatric training.

Authors:  Joanne Nguyen; Jennifer Lemons; Sharon Crandell; Hope Northrup
Journal:  Genet Med       Date:  2015-05-14       Impact factor: 8.822

Review 8.  Clinical evaluation of patients with a neuropsychiatric risk copy number variant.

Authors:  Samuel Jra Chawner; Cameron J Watson; Michael J Owen
Journal:  Curr Opin Genet Dev       Date:  2021-01-15       Impact factor: 4.665

9.  Overview: referrals for genetic evaluation from child psychiatrists.

Authors:  Katharine R Press; Laura Wieczorek; Julie Hoover-Fong; Joann Bodurtha; Lynn Taylor
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2016-03-28       Impact factor: 3.033

10.  Beyond hormone replacement: quality of life in women with congenital hypogonadotropic hypogonadism.

Authors:  Shota Dzemaili; Jitske Tiemensma; Richard Quinton; Nelly Pitteloud; Diane Morin; Andrew A Dwyer
Journal:  Endocr Connect       Date:  2017-07-11       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.